Therapy Areas: Cardiovascular
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
17 April 2024 - Germany-based pharmaceutical company Boehringer Ingelheim announced on Tuesday a strong acceleration of its pipeline in 2023, as pivotal trials in key research areas progressed as plan...
Nuevocor names new chief medical officer
12 April 2024 - Nuevocor, a pre-clinical stage biotechnology company, announced on Thursday that it has named Dr John Lee, MD, PhD, as its new chief Medical officer.Dr Lee, a life science executive, h...
Johnson & Johnson to acquire Shockwave Medical
5 April 2024 - Healthcare products company Johnson & Johnson (J&J) (NYSE:JNJ) and cardiovascular medical device company Shockwave Medical Inc (Nasdaq:SWAV) announced on Friday a definitive agr...
Haemonetics' TEG 6s hemostasis cartridge gains FDA clearance
4 April 2024 - Medical technology solutions company Haemonetics Corporation (NYSE:HAE) announced on Thursday that it has obtained US Food and Drug Administration (FDA) 510(k) clearance for its TEG 6s ...
Polymedco's PATHFAST hs-cTnI-II test receives US FDA clearance
28 March 2024 - US-based screening and early detection specialist Polymedco LLC announced on Wednesday that it has received US Food and Drug Administration (FDA) approval for the PATHFAST high-sensiti...
Gilgamesh Pharmaceuticals receives multi-year USD14m grant from NIDA
15 March 2024 - Gilgamesh Pharmaceuticals, a clinical-stage neuroscience company, announced on Thursday that it has received a multi-year USD14m grant from National Institute on Drug Abuse (NIDA).The ...